The heavy burden of cervical cancer in Mali

Cervical cancer remains a devastating reality for countless Malian women. Fatoumata, a 38-year-old woman, is one such victim. Her journey to diagnosis and treatment highlights the harsh challenges many face in accessing timely healthcare.

« I first had a fibroid and took time to treat it. It was only when I started experiencing bleeding that I underwent surgery. After the operation, I noticed unusual discharges – colorless and odorless, like water. I consulted my gynecologist, and the results confirmed cervical cancer. I spent between 5 and 6 million West African CFA francs on treatment. Just the surgery alone cost me two million francs. »

This personal account underscores the barriers to early detection and treatment in Mali, where quality healthcare remains out of reach for many. The delayed diagnoses and high costs of treatment contribute to thousands of preventable deaths annually.

Cultural barriers and misconceptions

Beyond medical challenges, cultural taboos further impede women’s ability to openly discuss symptoms. Superstitions and misconceptions often link cervical cancer to curses or witchcraft, delaying diagnosis and exacerbating outcomes. « Cervical cancer is sometimes perceived as a curse cast by a co-wife, sister-in-law, or former partner, » explains a sexual and reproductive health advocate.

A historic step: integrating HPV vaccination

In a landmark decision, the Malian government has recently integrated the HPV vaccine into its routine immunization schedule. Dr. Ibrahima Diarra, Director of the National Immunization Center, emphasized the importance of this milestone during the Bamako launch event: « A single dose provides protection for a 10-year-old girl for over a decade against the viruses responsible for 70% of cervical cancers. » The vaccine is now available free of charge for young girls, thanks to support from Gavi and co-financing from the Malian government.

With this initiative, Mali aims to shield over 320,000 girls annually, potentially reducing cervical cancer cases by nearly 90%. This could prevent more than 3,600 deaths among Malian women each year.

Advancing health equity through prevention

This vaccination program represents a significant leap toward equitable public health. Cervical cancer claims thousands of lives daily, particularly in low-income countries. In 2022 alone, 348,000 deaths were recorded globally, with 90% occurring in these countries. By introducing the HPV vaccine, Mali is taking a bold step toward making prevention accessible to all girls, regardless of whether they live in urban or rural areas.

Dr. Diarra explains the rationale behind targeting 10-year-olds: « We chose this age group because their cervixes are still healthy, before the onset of sexual activity, ensuring maximum vaccine efficacy. » This approach aligns with the World Health Organization’s (WHO) recommendation to prioritize vaccination for girls aged 9 to 14.

Mali stands out as one of the first Sahelian nations and the first Gavi-supported fragile and conflict-affected country to introduce the HPV vaccine.

The introduction of the HPV vaccine not only prevents cervical cancer but also reduces the financial burden of treating the disease. « A single dose costs around 150,000 West African CFA francs in private pharmacies, but thanks to Gavi’s support and Malian government co-financing, the vaccine is now free under the routine immunization program, » Dr. Diarra notes.

Mali’s pioneering initiative not only safeguards generations of Malian women but also sets an inspiring example for other countries in the region. This breakthrough aligns with Gavi’s global goals to vaccinate 86 million girls in low- and middle-income countries by 2025.

Combating misinformation and rumors

Malian health authorities are also tackling a critical challenge: vaccine misinformation. False claims and rumors sometimes circulate, fueled by opponents. « It is crucial to counter this misinformation. This vaccine is safe, effective, and does not compromise the fertility or reproductive health of young girls, » insists Dr. Diarra.

The Minister of Health, Colonel Assa Badiallo Touré, echoed this sentiment during the launch, reaffirming the vaccine’s safety and importance.

The introduction of the HPV vaccine is a monumental victory for women’s health and a step toward a more equitable future in Mali. By breaking the cycle of disease through prevention, the country demonstrates a public health model centered on equity, protecting the most vulnerable and ensuring a safer future for Malian women.